Ayala Pharmaceuticals Correlations

ADXSDelisted Stock  USD 1.38  0.34  32.69%   
The current 90-days correlation between Ayala Pharmaceuticals and Onconova Therapeutics is -0.04 (i.e., Good diversification). The correlation of Ayala Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Ayala Pharmaceuticals Correlation With Market

Good diversification

The correlation between Ayala Pharmaceuticals and DJI is -0.07 (i.e., Good diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Ayala Pharmaceuticals and DJI in the same portfolio, assuming nothing else is changed.
  
The ability to find closely correlated positions to Ayala Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Ayala Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Ayala Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Ayala Pharmaceuticals to buy it.

Moving against Ayala OTC Stock

  0.38DNLI Denali TherapeuticsPairCorr
  0.37VERA Vera TherapeuticsPairCorr
  0.33DSGN Design TherapeuticsPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
AEZSADMP
AEZSONTX
GHSIACST
ADMPONTX
  
High negative correlations   
ADMPGHSI
AEZSGHSI
ADMPACST
ACSTONTX
AEZSACST
GHSIONTX

Risk-Adjusted Indicators

There is a big difference between Ayala OTC Stock performing well and Ayala Pharmaceuticals OTC Stock doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Ayala Pharmaceuticals' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Ayala Pharmaceuticals Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ayala Pharmaceuticals otc stock to make a market-neutral strategy. Peer analysis of Ayala Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Ayala Pharmaceuticals by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Still Interested in Ayala Pharmaceuticals?

Investing in delisted otcs can be risky, as the otc stock is no longer traded on a public exchange and can therefore be difficult to sell. Delisting typically occurs when a company has failed to meet exchange requirements or has been acquired. Before investing, it's important to thoroughly research the company, including its financial health and prospects for the future, as well as the reasons for its delisting. Additionally, it may be difficult to find accurate and up-to-date information on the company and its stock.